Background Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a common illness with a major impact on quality of life. Recovery is poorly understood. Our aim was to describe definitions of recovery in paediatric CFS/ME, the rate of recovery and the time to recovery.
Methods This systematic review included a detailed search of MEDLINE, EMBASE, PsycInfo and Cochrane Library between 1994 and July 2018. Inclusion criteria were (1) clinical trials and observational studies, (2) participants aged <19 years with CFS/ME, (3) conducted in Western Healthcare systems and (4) studies including a measure of recovery and time taken to recover.
Results Twelve papers (10 studies) were identified, involving 826 patients (range 23–135). Recovery rates were highly varied, ranging between 4.5% and 83%.
Eleven distinct definitions of recovery were used; six were composite outcomes while five used unidimensional outcomes. Outcome measures used to define recovery were highly heterogeneous. School attendance (n=8), fatigue (n=6) and physical functioning (n=4) were the most common outcomes included in definition of recovery. Only five definitions included a personal measure of recovery.
Implications Definitions of recovery are highly variable, likely secondary to differences in study design, outcomes used, follow-up and study populations. Heterogeneous definitions of recovery limit meaningful comparison between studies, highlighting the need for a consensus definition going forward. Recovery is probably best defined from the child’s own perspective with a single self-reported measure. If composite measures are used for research, there should be agreement on the core outcome set used.
- adolescent health
- occupational therapy
Data availability statement
No additional data are available. All data discussed here has been published previously.
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
What is already known on this topic?
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a complex, common illness which substantially impacts on quality of life. Recovery is poorly understood and defined.
What this study adds?
Definitions of recovery are heterogeneous and recovery rates are variable. A consensus definition of recovery, focusing on patient perspective, is necessary to facilitate further research.
Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is common (prevalence 0.1%–2.4%1–4) and has a substantial impact on children. Over 50% of children are bed-bound at some stage of their illness4 and lose a mean total of 1 year of school.3 5
Recovery from illness remains poorly defined and highly variable between different conditions. Much of the research examining recovery has been focused on adults6 and has demonstrated a range of highly personal targets that patients associate with recovery. In the context of mental health, it is increasingly acknowledged that a single end-point of ‘recovery’ is neither realistic nor relevant for many patients.7 A systematic review examining recovery in adult CFS/ME found a broad range of outcomes were used to quantify recovery, with the most commonly used measure being a brief global rating.8 Few of the included papers in this review considered the patients’ individual perception of what they considered ‘recovery’ to be.
Little is known about recovery in paediatric CFS/ME. Recovery is highly personal and is described by children with CFS/ME in many different ways.9 This is further complicated by lack of consensus on the definition of recovery. A 1997 systematic review of prognosis of CF and CFS populations, based on four small observational studies (n=15–31) using different definitions of recovery, reported that 54%–94% made a good or complete recovery at 13–72 months.10
The objective of our systematic review was to describe definitions of recovery in paediatric CFS/ME, within interventional trials and observational studies. We also aimed to describe what proportion recover, time to recovery and whether recovery rate differs between younger (<12 years) and older children.
We included prospective studies (observational studies and clinical trials) which provided a measure of recovery (complete or partial) and time to recovery in children (<19 years) with CFS/ME, based within Western healthcare systems. We included studies where CFS/ME was defined using the CDC,11 NICE12 or Oxford criteria.13 Exclusion criteria included studies investigating children with fatigue due to other causes and chronic fatigue not defined using the aforementioned criteria. A pre-specified protocol was used and registered prospectively on PROSPERO (registration number: CRD42014009303).
We conducted a systematic literature search of MEDLINE, EMBASE, PsychInfo and the Cochrane Library from 1994 to July 2014. We then updated this search to July 2018. We searched trial registration sites, hand searched reference lists and contacted authors for unpublished results. There were no language restrictions. Search terms for Ovid MEDLINE are presented in online supplemental appendix 1.
Two researchers (EMC and AR) independently assessed titles and abstracts identified from electronic database searches from 1994 to 2014. The updated search from 2014 to 2018 was completed by two different researchers (PS and AB). All potentially relevant papers underwent independent full-text review by two different reviewers (YM and NA). Eligibility was assessed using predefined inclusion criteria. Data were independently extracted by two researchers (YM and NA) onto purpose-designed forms. Disagreements were discussed and resolved through discussion with a third researcher. Data were extracted on CFS/ME diagnostic criteria used, treatment/interventions provided, definition of recovery, study setting, recruitment method, date of the study and child characteristics. The rate of recovery was calculated as the number recovered divided by the number randomised for randomised studies or the number recovered divided by the number followed up for observational studies.
Defining outcome measures
Outcomes were interpreted in the following way. Where single outcomes were measured (even if several were used in one study) and used to define recovery, this was termed a ‘unidimensional outcome’. Where numerical values for several unidimensional outcomes were combined, this was termed a ‘composite’ outcome. Where possible, the ‘proportion recovered’ has been reported for each dimension within a composite outcome.
Given the broad scope of this review, substantial heterogeneity was identified among selected studies, in terms of design, populations, intervention and outcome. Formal meta-analysis was not possible due to insufficient comparable data and so narrative synthesis was chosen as the most appropriate method.
Description of studies
Figure 1 describes the cumulative summary of search results from original and updated searches. Of 1577 papers identified, 117 underwent full-text review for eligibility. The final sample included 12 papers presenting data from 10 studies. For our description of definitions of recovery, each paper was the unit of interest, and for our description of recovery rates, each study was the unit of interest.
Table 1 describes the studies and papers included. Sample sizes varied between 2314 and 135.15 Mean age was between 14.216 and 16 years17 (range 10–19 years). Three papers did not report details of participants’ ages.14 18 19 The majority of participants were female (range 63%16–90%18 20).
There were four randomised treatment trials. Two trials were also reported in long-term follow-up papers21 22—therefore six papers in total. One of these two follow-up papers did not report separate recovery rates for intervention and control groups.22 Children were offered cognitive-behavioural therapy (CBT: individual only, family-focused, telephone or internet based),15 20–23 psychoeducation21 23 and gammaglobulin therapy.19 There were six observational studies. One involved an inpatient treatment programme,24 the remainder involved outpatient treatments. Outpatient treatments included CBT (family-focused14), specialist medical care,3 graded activity and exercise programmes with sessions targeting ‘practical management issues’16 and ‘regular care’.17 One observational study did not involve any intervention.18 One study identified children after school-based screening.3 Mean follow-up for included studies was wide (range 1.5 months3 to 56 months19).
Definition of recovery
Recovery was explicitly defined in four papers.15 17 21 22 In the remaining papers, recovery was implied from the outcome measures reported. In studies using patient-reported outcomes, those who were ‘completely back to normal’ or whose symptoms ‘resolved’ were assumed to be ‘recovered’.24
Definitions of recovery used were varied (table 2). Twelve papers used 11 different definitions. Of these, three used one outcome to define recovery3 19 23 and nine reported several outcomes.14–18 20–22 24 In seven papers, outcomes were combined into a composite measure of recovery.14–18 21 22 Three of these seven had a composite outcome as their primary outcome.14 17 18 The remaining four had unidimensional primary outcomes.15 16 21 22 Three reported both composite outcomes and separate recovery rates for each domain within the composite outcome.15 17 22
Of the nine papers using several unidimensional definitions, seven included change in fatigue,14 15 17 20–22 24 seven incorporated school attendance14–16 20–22 24 and five used improvement in physical function.15 17 20 22 24 One used clinical examination and investigations to identify recovered participants.18 Another paper used self-reported ratings on physical activity, fatigue, cognition and social activities. Those who reported being ‘completely back to normal’ or whose symptoms ‘resolved’ were assumed to be ‘recovered’ and symptoms ‘better or resolved’ was assumed to indicate partial recovery or recovery.24 One paper included a measure of global wellness.16 Patient-reported measures of improvement or ‘recovery’ were used in six papers.
Of the three papers using only one unidimensional definition, two used school attendance3 23 and one used self-rated improvement on a questionnaire.19 In our analysis of the latter, we interpreted self-rated improvement where “participants considered they were well” as an indication that they had recovered.19
Substantial heterogeneity among outcome measures was noted. There were 11 different outcome measures used within the studies included (table 2). Different methods and thresholds were used to record each outcome. Physical functioning was measured by the Child Health Questionnaire—child form 87 (CHQ-CF87),15 17 22 or an unspecified “self-administered questionnaire with multiple choice answer” in one study.24 Fatigue was measured using the Chalder Fatigue Scale,14 21 fatigue severity sub-scale of CIS-2015 17 22 and the unspecified questionnaire.24 School attendance was measured by parents, telephone contact with the school, self-report and other unreported methods. Different thresholds were assumed to indicate recovery, from >70%23 to full-time school attendance.3 Cut-off scores used were variable. On the CIS-20, a score of <40 was required.15 17 22 On physical functioning subscale CHQ-CF87, scores of ≥8515 22 and >6517 were used.
Two of the 12 papers reported their rationale for their chosen definition of recovery.16 21 Lloyd et al21 used a cut-off on the Chalder Fatigue Scale previously used in the PACE trial.25 School attendance was also incorporated due to the impact of CFS/ME on educational and social development. Viner et al16 incorporated a Global Wellness score as a marker for overall health and quality of life, previously used in adult CFS/ME studies. School attendance was used as a surrogate marker of an individual’s “functional status” and ability to “participate in normal life”. The remaining 10 papers did not explain their choice of outcome(s) used to define recovery.
Proportion of children who recover
Recovery rates at follow-up ranged from 4.5%16 to 83%14 (mean follow-up time 6–56 months) across all reported results from the 12 papers, including both treatment and control arms (table 2). Within the RCTs which reported separate recovery rates, children allocated to interventions had higher recovery rates compared with controls. Within intervention arms, recovery rates ranged from 43% to 79% (follow-up time 5–24 months).15 20 21 23 In control groups, recovery rates ranged from 4.5%16 to 64%21 (mean follow-up time 6–24 months). Recovery rates were lowest where the control arm constituted ‘supportive care’, ‘usual care’ or ‘waiting list’, ranging from 4.5%16 to 21%.20 In one RCT (reported in two papers), the control arm constituted psychoeducation. Here, recovery rates ranged from 29% to 65%23 (mean follow-up 3 months to 24 months). Within observational studies, recovery rates ranged from 19% to 83% (mean follow-up time 6 months to 3.5 years).
Recovery rates were lower when composite outcomes were used (table 2). Chalder showed that 95% of children were meeting recovery thresholds at 6-month follow-up when defined as school attendance >75%.14 However, this recovery proportion fell to 83% when school attendance was combined with fatigue score >4 on Chalder Fatigue Scale as part of a composite definition of recovery.14
Do recovery rates change over time?
Exact time to recovery was not reported in any of the included papers.
Six papers specifically reported recovery at 6 months.3 14–16 18 23 Recovery rate ranged from 58% to 83% in the intervention groups.14 15 23 All interventions involved CBT and one involved psychoeducation.23 Recovery was lower in children receiving usual care or no intervention at 6 months (range: 8%15 to 31%18).
Two papers reported recovery at 12 months.15 23 A recovery rate of 64% was reported in those receiving CBT, compared with 8% in those receiving usual care.15 Recovery rates were stable between 6 and 12 months in both arms.15 The other found 59% recovered following CBT, while 65% recovered after psychoeducation.23
Six papers reported recovery rates at multiple time points.3 15 18 22–24 Four of these showed increased recovery rates over time.3 18 22 24 One showed improvement in the control arm (psychoeducation) but lower recovery rates in the intervention arm between 6 and 12 months.23
The included papers primarily involved teenage participants. Few included younger children (<12 years old); where they were included, data specifically for this population were not available. No papers specifically explored recovery in a primary school–aged population. As a result, we were unable to comment on whether recovery rates differ in younger populations.
This is the first contemporary systematic review exploring both recovery rates and definitions of recovery in paediatric CFS/ME in those receiving either specialist care or no intervention. A broad range of definitions of recovery were identified, which, in part, resulted in highly varied recovery rates. School attendance and fatigue represented the two most common measures used to define recovery. The majority of studies defined recovery according to multiple parameters. Few studies included in our review examined children’s perceptions of recovery or considered which aspects were most meaningful to them.
Across all studies, children receiving no treatment had recovery rates ranging from 21% to 52%. Children receiving ‘usual care’ had recovery rates ranging from 4.5% to 63%. Recovery rates were higher among children offered intensive interventional treatment, ranging from 43% to 83%. Highly varied recovery rates are likely, in part, secondary to the heterogeneous definitions of recovery used and the broad range of outcome measures used within these definitions. Interpretation is also challenging due to lack of clearly defined interventions/controls and varied follow-up time.
Strengths and weaknesses
Strengths of this review include its comprehensive search strategy and rigorous study selection progress. A detailed search was conducted in four databases, identifying data published over the last 24 years. Reference lists and trial registration websites were hand searched to reduce publication bias. Strict eligibility criteria facilitated improved comparison of results. We were unable to locate 17 papers. We included papers in any language but excluded studies conducted outside Western healthcare systems. This limits interpretation of our results in other healthcare settings.
Interpretation was challenging due to the variety of definitions of recovery used, with different methods and thresholds used to measure and define outcomes. The clinical significance or rationale used to determine thresholds was rarely explained or justified.
Nine of the 10 studies recruited participants from tertiary care. One study used CFS/ME severity thresholds (CIS-20 score below cut-off) when recruiting participants, excluding participants with less severe symptoms.17 This limits the generalisability of our results as the populations included may over-represent those most severely affected by CFS/ME with a worse prognosis.3
Certain groups of children affected by CFS/ME were not evaluated in the included studies. Four studies excluded participants with comorbid psychiatric conditions.14 15 20 23 This may represent an attempt to avoid confounding due to improvement in comorbid mental health disorders, rather than CFS/ME recovery. This is particularly important given several studies involved psychological interventions. However, given the high prevalence of comorbid mental health disorders within the CFS/ME population,26 this may limit the applicability of these results. As studies included did not assess children under 10 years old, we cannot comment on recovery rates in this age group. This warrants further research going forward.
Substantial heterogeneity will exist among the quality, quantity and nature of standard treatment provided to those receiving ‘usual care’, due to differences in local provisions.15 16 22 Likewise, substantial heterogeneity between the intensity, length, mode of delivery and approach of interventions made comparison challenging. Recovery rates were lower when composite outcome measures were used to define recovery. With the exception of one study,14 recovery was higher in interventional trials compared with observational studies. Papers variably reported the number of recovered children as a proportion of either those randomised or those followed up. This skewed our ability to interpret recovery rates.
The data presented in the literature reviewed meant we were unable to comment on two of our initial review questions that discussed the extent to which participant age determined prognosis and the time to recovery.
Results in the context of previous literature
This paper is the first and only contemporary systematic review of recovery in paediatric CFS/ME. Recovery rates reported here are consistent with the only other systematic review conducted over 20 years ago in 1997, which found 54%–94% of children reported they had recovered or made a ‘definite improvement’ over 13–72 months. The 1997 review exclusively used patient-reported or parent-reported outcomes. In contrast, our findings demonstrate the use of a range of different measures, including objective and patient-reported measures, to classify recovery. This review also solely focuses on paediatric CFS/ME unlike the previous review which included both adult and paediatric populations.
‘Recovery’ is a complex concept which varies between patients.9 There is currently no consensus definition for recovery in paediatric CFS/ME which limits comparison between studies. Of the papers included in our review, nine used multiple outcomes to measure recovery but only five included the patients’ own perspective to address the component of ‘personal recovery’.15 16 19 20 22 The majority of included studies used at least one objective measure of recovery, such as school attendance. Patient-reported measures are likely to be crucial in developing a definition of recovery which is meaningful to children and families.9 27 28 Data from this review also suggest that recovery rates may be overestimated if single outcome measures are used, consistent with adult CFS/ME studies,29 and also may highlight selective rather than global improvement. This suggests that in the absence of a personal measure of recovery, composite measures may more adequately encompass the complexity of ‘recovery’.
Substantial heterogeneity in definitions of recovery, and outcome measures used therein, likely results in highly varied recovery rates across different studies and definitions. Although there is a suggestion of improved recovery rates among children offered specialist care, this review did not seek to examine intervention effectiveness. Going forward, there is a need to develop a consensus definition of ‘recovery’ in paediatric CFS/ME.
Given the personal and varied experiences of children with CFS/ME, what children feel define recovery is probably best defined from the child’s own perspective with a single self-reported measure of whether they feel they have recovered or not. This could also allow children to quantify their experience on a spectrum, between ‘unwell’ and ‘well’, which may be more easily intelligible compared with describing themselves as ‘recovered’. That said, a single outcome measure is vulnerable to distortion by encompassing multiple aspects of a child’s overall health status. Using multiple outcomes may help identify specific limitations or challenges children face secondary to their illness. Composite measures may, therefore, be more useful in a research context. If composite measures encompassing multiple parameters are used for research, these should be agreed as a core outcome set that is relevant to the child, their families and those around them.
Data availability statement
No additional data are available. All data discussed here has been published previously.
Contributors EMC and JH were involved in the conception and design of the article. EMC, AR, AB, YM, NA and PS participated in the literature search and selection. YM, TS, NA, HK, AB, PS, CA and PC made substantial contributions to data acquisition. YM, TS, NA, HK, AB, JH, PS and PC were involved in the analysis and interpretation of the data.
Funding EMC was funded by the National Institute for Health Research (Senior Research Fellowship, SRF-2013-06-013).
Disclaimer The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.
Competing interests EMC is an unpaid medical advisor to The Sussex & Kent ME Society. EMC, one of the authors of this systematic review, was also an author of one of the included papers. However, to avoid a conflict of interest, EMC was not involved in the final study selection or data extraction.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.